Curtis Lisle

Dr. Curtis Lisle

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2022 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
David MilewskiDavid Milewski
David Milewski
HJHyun Jung
Hyun Jung
GBG. Thomas Brown
G. Thomas Brown
YLYanling Liu
Yanling Liu
BSBen Somerville
Ben Somerville
JKJaved Khan
Javed Khan
Purpose: Rhabdomyosarcoma (RMS) is an aggressive soft-tissue sarcoma, which primarily occurs in children and young adults. We previously reported specific genomic alterations in RMS, which strongly correlated with survival; however, predicting these mutations or high-risk disease at diagnosis remains a significant challenge. In this study, we utilized convolutional neural networks (CNN) to learn histologic features associated with driver mutations and outcome using hematoxylin and eosin (H&E) images of RMS. Experimental Design: Digital whole slide H&E images were collected from clinically annotated diagnostic tumor samples from 321 patients with RMS enrolled in Children's Oncology Group (COG) trials (1998–2017). Patches were extracted and fed into deep learning CNNs to learn features associated with mutations and relative event-free survival risk. The performance of the trained models was evaluated against independent test sample data (n = 136) or holdout test data. Results: The trained CNN could accurately classify alveolar RMS, a high-risk subtype associated with PAX3/7-FOXO1 fusion genes, with an ROC of 0.85 on an independent test dataset. CNN models trained on mutationally-annotated samples identified tumors with RAS pathway with a ROC of 0.67, and high-risk mutations in MYOD1 or TP53 with a ROC of 0.97 and 0.63, respectively. Remarkably, CNN models were superior in predicting event-free and overall survival compared with current molecular-clinical risk stratification. Conclusions: This study demonstrates that high-risk features, including those associated with certain mutations, can be readily identified at diagnosis using deep learning. CNNs are a powerful tool for diagnostic and prognostic prediction of rhabdomyosarcoma, which will be tested in prospective COG clinical trials.

4 December 2024 in Agronomy
Verified
Journal Article
Open access
PDF file
DPDebasmita Pal
Debasmita Pal
KSKevin Schaper
Kevin Schaper
ATAddie Thompson
Addie Thompson
JGJessica Guo
Jessica Guo
PJPankaj Jaiswal
Pankaj Jaiswal
ARArun Ross
Arun Ross
Genome-wide association studies (GWAS) are widely used to infer the genetic basis of traits in organisms; however, selecting appropriate thresholds for analysis remains a significant challenge. In this study, we introduce the Sequential SNP Prioritization Algorithm (SSPA) to investigate the genetic underpinnings of two key phenotypes in Sorghum bicolor: maximum canopy height and maximum growth rate. Using a subset of the Sorghum Bioenergy Association Panel cultivated at the Maricopa Agricultural Center in Arizona, we performed GWAS with specific permissive-filtered thresholds to identify genetic markers associated with these traits, enabling the identification of a broader range of explanatory candidate genes. Building on this, our proposed method employed a feature engineering approach leveraging statistical correlation coefficients to unravel patterns between phenotypic similarity and genetic proximity across 274 accessions. This approach helps prioritize Single Nucleotide Polymorphisms (SNPs) that are likely to be associated with the studied phenotype. Additionally, we conducted a complementary analysis to evaluate the impact of SSPA by including all variants (SNPs) as inputs, without applying GWAS. Empirical evidence, including ontology-based gene function, spatial and temporal expression, and similarity to known homologs demonstrates that SSPA effectively prioritizes SNPs and genes influencing the phenotype of interest, providing valuable insights for functional genetics research.

1 April 2023
Verified
Other
Open access
David MilewskiDavid Milewski
David Milewski
HJHyun Jung
Hyun Jung
GBG. Thomas Brown
G. Thomas Brown
YLYanling Liu
Yanling Liu
BSBen Somerville
Ben Somerville
JKJaved Khan
Javed Khan
Supplemental Figure S4. Sample partitioning for training a MYOD1 mutation predictive model using K-fold cross-validation.


25 November 2025
Verified
Other
Open access
David MilewskiDavid Milewski
David Milewski
HJHyun Jung
Hyun Jung
GBG. Thomas Brown
G. Thomas Brown
YLYanling Liu
Yanling Liu
BSBen Somerville
Ben Somerville
JKJaved Khan
Javed Khan
Supplemental Table S1. Whole slide image tissue segmentation statistics by an expert pathologist and probability prediction using a trained convolutional neural network. Supplemental Table S2. Clinical and molecular characteristics of FN-RMS samples used for training models for mutation prediction. Yellow boxes indicate genes included in defining the RAS pathway. Supplemental Table S3. Clinical information with COG risk stratification of FN-RMS samples used for training a prognostication predictive CNN.

1 April 2023
Verified
Other
Open access
David MilewskiDavid Milewski
David Milewski
HJHyun Jung
Hyun Jung
GBG. Thomas Brown
G. Thomas Brown
YLYanling Liu
Yanling Liu
BSBen Somerville
Ben Somerville
JKJaved Khan
Javed Khan
Supplemental Table S1. Whole slide image tissue segmentation statistics by an expert pathologist and probability prediction using a trained convolutional neural network. Supplemental Table S2. Clinical and molecular characteristics of FN-RMS samples used for training models for mutation prediction. Yellow boxes indicate genes included in defining the RAS pathway. Supplemental Table S3. Clinical information with COG risk stratification of FN-RMS samples used for training a prognostication predictive CNN.